Sanctions Lists Harmonization Act

1) The Sanctions Lists Harmonization Act (HR4291) was introduced on July 2, 2025, by Rep. Fine (R-FL) with 9 cosponsors, and was ordered to be reported out of committee by a unanimous 49-0 vote on December 3, 2025. It currently awaits floor action in the House. The bill does not impose new sanctions, cut off funding, or create new enforcement mechanisms—it simply requires federal officials administering one sanctions list (e.g., OFAC's SDN list) to notify and request review by officials administering other lists (e.g., Commerce's Entity List, State's designated entities) within 30 days, and to make inclusion determinations within 90 days. 2) The bill authorizes zero dollars in funding. There is no appropriation, no contract authorization, and no grant program. The mechanism is purely procedural: interagency coordination and reporting. The only costs are administrative compliance costs for federal agencies, not private contractors. 3) Defense primes (LMT, RTX, NOC, BA) are the most plausibly affected private entities because they operate global supply chains subject to U.S. sanctions regimes. However, the bill merely requires existing lists to be cross-checked—it does not expand the substantive criteria for inclusion. Companies already face robust compliance requirements under ITAR, EAR, OFAC regulations, and the proposed harmonization adds marginal administrative burden rather than material business risk. No pure-play sanctions compliance technology companies exist that would benefit significantly, as most compliance software is embedded within larger platforms (e.g., LexisNexis Risk Solutions, not public; Refinitiv, part of LSEG). 4) As of this analysis, no market price data has been provided. The market has not reacted to this procedural bill, as it has not moved past committee. No real stock price movements are attributable to this legislation. 5) The next legislative steps are: House floor consideration (scheduling indefinite), potential Senate referral if passed by House, then potential committee markup and floor vote. Given the unanimous committee vote and bipartisan nature (co-sponsored by a Republican and a Democrat), passage probability is moderately high but timeline is uncertain. The bill's narrow procedural scope means even if passed, market impact will be neutral.